Loading contract…
BETAThis is a new independent transparency project, not an official government website. The data is sourced from public registers and may contain errors, so always verify against the official source. If you find a problem, please report it here.
This procurement is for the supply of adjuvanted trivalent influenza vaccine and cell culture-based quadrivalent influenza vaccine (Flucelvax) to NHSScotland for use in the annual seasonal influenza immunisation programme in General Practices and Hospitals across NHSScotland.
| Supplier | Identifier | Award Value | Lots Won | Cross-References |
|---|---|---|---|---|
| Seqirus UK Limited | 09614642 | - | 2 lots NP93820a Adjuvanted Trivalent Influenza Vaccine · NP93820b Flucelvax | LOBBYIST APCO Worldwide Ltd (1 quarter) |
This procurement was divided into 2 lots, each awarded separately. 2 bids were received in total.
| Lot | Value | Bids Received | Awarded To | Status |
|---|---|---|---|---|
| Lot 1 NP93820a Adjuvanted Trivalent Influenza Vaccine | £5,742,000 initial term | 1 single bid — no competition | Seqirus UK Limited | complete |
| Lot 2 NP93820b Flucelvax | £4,238,872 initial term | 1 single bid — no competition | Seqirus UK Limited | complete |
Weightings from the notice, applied to every lot.
Government spending data: This supplier has received £66,759,617 in 98 payments (over £25k) from Department of Health and Social Care, UK Health Security Agency, Guy's and St Thomas' NHS FT, Manchester University NHS Foundation Trust, Royal Cornwall Hospitals NHS Trust and 10 more public bodies (2019-11-26 to 2026-01-09). View full payment history →